Markets / IPO / Senores Pharmaceuticals

Senores Pharmaceuticals IPO

Updated 19:46

Mainboard IPO on NSE and BSE · Pharmaceuticals

Status
Listed
Price band
₹372–391
Lot size
38 shares · ₹14,858
Subscribed
93.69×

How it listed

Issue price
₹391
Listing price (open)
₹600.00 +53.45%
First-day close
₹557.05 +42.47%
Price now
₹1,161.00 +196.93%
Listing day30 Dec 2024
Open / high / low / close₹600.00 / ₹609.65 / ₹538.85 / ₹557.05
Shares traded on NSE1,42,34,437
Market value at the listing-day close₹2,565 cr

Closing prices since listing: 26 Oct ₹1,245.50, 27 Oct ₹1,311.00, 28 Oct ₹1,324.30, 29 Oct ₹1,219.20, 30 Oct ₹1,133.90, 2 Nov ₹1,119.60, 3 Nov ₹1,147.00, 4 Nov ₹1,137.00, 5 Nov ₹1,187.90, 6 Nov ₹1,155.20.

Senores Pharmaceuticals share price, live chart and technicals →

Key dates

Bidding opens20 Dec 2024
Bidding closes24 Dec 2024
Allotment25 Dec 2024
Refunds and shares in demat26 Dec 2024
Listing30 Dec 2024

Issue reservation

Investor groupShares% of issueMost applicants allotted
Anchor investors66,65,72543.85%–
Institutions (QIB)45,93,21630.22%–
HNI / NII23,19,87915.26%–
  HNI, above ₹10 lakh15,46,58610.17%598
  HNI, ₹2–10 lakh7,73,2935.09%1,453
Retail15,46,58610.17%40,699
Employees75,0000.49%–

Shares NSE lists as offered to each group, plus the anchor portion. "Most applicants allotted" is how many people can get the minimum application in that group when it is oversubscribed.

Lot size by investor type

ApplicationLotsSharesAmount
Retail (minimum)138₹14,858
Retail (maximum)13494₹1,93,154
Small HNI (minimum)14532₹2,08,012
Small HNI (maximum)672,546₹9,95,486
Big HNI (minimum)682,584₹10,10,344

At ₹391 a share. Retail bids go up to ₹2 lakh, small HNI from ₹2 lakh to ₹10 lakh, big HNI above ₹10 lakh.

Chance of getting shares (retail)

Chance
At least 1 in 90
Retail allotments available
40,699 × one lot
Retail portion subscribed
90.46×

An estimate from the times the retail portion was subscribed, as if every applicant bid for the minimum. Many bid for more lots, so the real chance is usually better. Winners are picked by lottery and each gets the minimum (one lot).

Subscription

Investor categoryShares offeredShares bid forTimes subscribed
Institutions (QIB)45,93,21643,47,78,10294.66×
HNI / NII23,19,87922,33,98,73296.30×
  HNI, above ₹10 lakh15,46,58614,46,53,76493.53×
  HNI, ₹2–10 lakh7,73,2937,87,44,968101.83×
Retail15,46,58613,99,04,33490.46×
Employees75,00015,15,47820.21×
Total85,34,68179,95,96,64693.69×

NSE and BSE bids together, as of 24 Dec 2024 19:00.

Demand at each price

Top price ₹3916,716.74 lakh shares83.9%
Cut-off final price, whatever it is; mostly retail1,281.27 lakh shares16.0%
Lower prices ₹372–3905.59 lakh shares0.1%

Shares bid on NSE and BSE at each price in the band. Most bids at the top price, and little at lower prices, means buyers were keen.

Anchor investors

Anchor bid date19 Dec 2024
Anchor shares66,65,725
Raised from anchors₹260.63 cr
Lock-in ends for the first 50% (30 days)23 Jan 2025
Lock-in ends for the remaining 50% (90 days)24 Mar 2025

Anchor investors are large funds that buy the day before the IPO opens. SEBI locks in half their shares for 30 days from the allotment and the rest for 90 days; they can sell from the next trading day. Traders watch these dates because extra selling can come in.

Financials and valuation

At issue priceNow
Market value₹1,801 cr₹5,346 cr
P/E (last 12 months' profit)16.950.0
Revenue, last 12 months₹548 cr
Profit, last 12 months₹107 cr
Return on equity10.7%
Debt to equity0.39

From results the company filed with NSE (latest period to 30 Sept 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.

Other recent IPOs: Pharmaceuticals

CompanyListedSubscribedOn listingSince IPO
Symbiotec Pharmalab 1 Sept71.26×0.00%+53.20%
Bio Medica Laboratories SME29 May–-20.00%+4.57%
Sai Parenteral's 2 Apr1.05×+2.04%+18.97%
KRM Ayurveda SME29 Jan–+27.48%+68.89%
Corona Remedies 15 Dec137.04×+38.42%+129.86%
Curis Lifesciences SME14 Nov–+14.14%+38.36%
Rubicon Research 16 Oct103.90×+27.84%+242.12%
Amanta Healthcare 9 Sept82.61×+7.14%+54.98%

IPO details

Price band₹372–391
Final issue price₹391
Lot size38 shares
Minimum investment₹14,858 (1 lot)
MarketNSE mainboard
Issue type100% Book Building
Face valueRe 10 per Equity Share
IndustryPharmaceuticals
Issue size₹164.22 crore (about 42.00 lakh shares) · Fresh issue + offer for sale: fresh ₹82.11 cr, offer for sale ₹82.11 cr
ISININE0RB801010
RegistrarLink Intime India Private Limited
Helpline: +91 8108114949, senorespharma.ipo@linkintime.co.in
Lead managersEquirus Capital Private Limited, Ambit Private Limited and Nuvama Wealth Management Limited
ProspectusRed herring prospectus (NSE)

Check allotment status

Allotment was finalised on 25 Dec 2024. Check it on the registrar's page (Link Intime India Private Limited), NSE or BSE with your PAN or application number.

← All IPOs: open, upcoming and recently listed

From NSE's official IPO data. Expected dates follow SEBI's T+3 timetable; the exchange confirms them. Information only, not investment advice.

What is the Senores Pharmaceuticals IPO price band and lot size?

The price band is ₹372–391 per share, and one lot is 38 shares (₹14,858 at the upper price).

When is the Senores Pharmaceuticals IPO allotment date?

Allotment was finalised on 25 Dec 2024, the next working day after bidding closed on 24 Dec 2024.

How many times was the Senores Pharmaceuticals IPO subscribed?

In total 93.69 times, on NSE and BSE together; retail 90.46 times.

What is the Senores Pharmaceuticals IPO listing date?

It listed on 30 Dec 2024 on NSE and BSE.

What is the chance of getting Senores Pharmaceuticals IPO shares?

At least 1 in 90 retail applicants got the minimum lot: 40,699 retail allotments with the retail portion subscribed 90.46 times. Winners are picked by lottery.

When does the Senores Pharmaceuticals anchor lock-in end?

The 30-day lock-in on half of the anchor investors' shares ends on 23 Jan 2025 and the 90-day lock-in on the rest ends on 24 Mar 2025; they can sell from the next trading day.

What was the Senores Pharmaceuticals listing gain?

It opened at ₹600.00 against an issue price of ₹391, a gain of 53.45%. It is now up 196.93% from the issue price.